Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Farde

Showing results (141-150 of 218) with videos related to

Pageof 22
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2015
Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson DiseasePatrik Fazio, Per Svenningsson, Anton Forsberg, et al.
Neuropharmacology|April 3, 2018
The metabotropic glutamate receptor 5 radioligand [<sup>11</sup>C]AZD9272 identifies unique binding sites in primate brainKatarina Varnäs, Anders Juréus, Sjoerd J Finnema, et al.
Neuroimage|June 23, 2009
Modulation of striatal dopamine D1 binding by cognitive processingSari Karlsson, Lars Nyberg, Per Karlsson, et al.
Addiction (Abingdon, England)|January 30, 2023
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkersSimon Jangard, Nitya Jayaram-Lindström, Nils Hentati Isacsson, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2025
Brain exposure of the mesenchymal-epithelial transition inhibitor savolitinib in nonhuman primates: A positron emission tomography studyPeter Johnström, Zsolt Cselényi, Kowser Miah, et al.
Brain : a Journal of Neurology|July 4, 2006
Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor bindingSimon Cervenka, Sven E Pålhagen, Robert A Comley, et al.
Synapse (New York, N.Y.)|September 3, 2005
[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PETChrister Halldin, Johan Lundberg, Judit Sóvágó, et al.
Nuclear Medicine and Biology|September 27, 2017
[<sup>11</sup>C]AZ10419096 - a full antagonist PET radioligand for imaging brain 5-HT<sub>1B</sub> receptorsAnton Lindberg, Sangram Nag, Magnus Schou, et al.
NPJ Schizophrenia|September 22, 2021
No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosisMaria Lee, Helena Fatouros-Bergman, Pontus Plavén-Sigray, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 10, 2008
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibilityJussi Hirvonen, Jarkko Johansson, Mika Teräs, et al.
Pageof 22

Showing results (141-150 of 218) with videos related to

Sort By:
Pageof 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2015
Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson DiseasePatrik Fazio, Per Svenningsson, Anton Forsberg, et al.
Neuropharmacology|April 3, 2018
The metabotropic glutamate receptor 5 radioligand [<sup>11</sup>C]AZD9272 identifies unique binding sites in primate brainKatarina Varnäs, Anders Juréus, Sjoerd J Finnema, et al.
Neuroimage|June 23, 2009
Modulation of striatal dopamine D1 binding by cognitive processingSari Karlsson, Lars Nyberg, Per Karlsson, et al.
Addiction (Abingdon, England)|January 30, 2023
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkersSimon Jangard, Nitya Jayaram-Lindström, Nils Hentati Isacsson, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2025
Brain exposure of the mesenchymal-epithelial transition inhibitor savolitinib in nonhuman primates: A positron emission tomography studyPeter Johnström, Zsolt Cselényi, Kowser Miah, et al.
Brain : a Journal of Neurology|July 4, 2006
Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor bindingSimon Cervenka, Sven E Pålhagen, Robert A Comley, et al.
Synapse (New York, N.Y.)|September 3, 2005
[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PETChrister Halldin, Johan Lundberg, Judit Sóvágó, et al.
Nuclear Medicine and Biology|September 27, 2017
[<sup>11</sup>C]AZ10419096 - a full antagonist PET radioligand for imaging brain 5-HT<sub>1B</sub> receptorsAnton Lindberg, Sangram Nag, Magnus Schou, et al.
NPJ Schizophrenia|September 22, 2021
No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosisMaria Lee, Helena Fatouros-Bergman, Pontus Plavén-Sigray, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 10, 2008
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibilityJussi Hirvonen, Jarkko Johansson, Mika Teräs, et al.
Pageof 22